Capsulomics, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Clinical Utility of Methylation-based Prognostic Assay for Barrett's Esophagus (NCT05846971) | Capsulomics, Inc. | 2021-01-26 |
Track Capsulomics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.